PFM Health Sciences’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-110,000
Closed -$28.6M 89
2025
Q3
$28.6M Buy
+110,000
New +$28.9M 2.2% 11
2021
Q4
Sell
-21,000
Closed -$8.17M 82
2021
Q3
$8.17M Buy
+21,000
New +$8.91M 0.24% 67
2019
Q2
Sell
-393,100
Closed -$105M 93
2019
Q1
$105M Buy
+393,100
New +$113M 2.31% 9
2018
Q1
Sell
-82,200
Closed -$20.4M 97
2017
Q4
$20.4M Buy
+82,200
New +$20.3M 0.48% 64

Other funds holding HUM

PFM Health Sciences's HUM Position: Q2 2026 in Review

PFM Health Sciences opened a new position in Humana (HUM) in Q2 2026: 94,375 shares worth $37.5M. The stake represents 3.22% of the portfolio and ranks #5 among its holdings. This is a return to the name: PFM Health Sciences previously reported a position in HUM as recently as Q3 2025.

PFM Health Sciences first reported a position in HUM in Q3 2013 and has held it in 46 quarters since. The position peaked at $149M in Q2 2019. 925 funds tracked by Wall St. Rank hold HUM as of Q2 2026.

  • PFM Health Sciences held 94,375 shares of Humana worth $37.5M as of Q2 2026.
  • Humana was a new PFM Health Sciences position in Q2 2026.
  • Humana made up 3.22% of PFM Health Sciences's portfolio in Q2 2026, its #5 holding.
  • PFM Health Sciences first reported a position in Humana in Q3 2013 and has held it in 46 quarters since.
  • PFM Health Sciences's Humana position peaked at $149M in Q2 2019.
  • 925 funds tracked by Wall St. Rank held Humana as of Q2 2026.

Based on PFM Health Sciences's 13F filing for Q2 2026, filed 14 Aug 2026.